MAPK signaling is commonly activated in pediatric low grade gliomas through BRAF fusions suggesting this rather than PI3K signaling may commonly activate mTOR signaling in these tumors [108, 109]. This evidence concerns the gene PIK3CA and central nervous system cancer.